Clinical Trial Update: Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial enrolling to assess arginine therapy for pain in children with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Emory University | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: RECRUITING